Institut de cancerologie Gustave Roussy

Villejuif 94805

2 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Adenoid Cystic Carcinoma, Advanced and Metastatic Urothelial Cancer, Cholangiocarcinoma, Follicular Lymphoma (FL), Glioblastoma Multiforme, Adult, Higher Risk Myelodysplastic Syndromes, Marginal Zone Lymphoma, Metastatic Adenoid Cystic Carcinoma, Myelodysplastic Syndromes, Non Hodgkin Lymphoma

Studies at this site

• Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma — Recruiting now
• Study of REM-422 in Patients With AML or Higher Risk MDS — Recruiting now
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme — Running, not enrolling
• Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma — Stopped early
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early
• Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma — Stopped early